This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB04619/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB04619/identifier/drugbank/
n8http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB04619/identifier/chebi/
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://linked.opendata.cz/resource/drugbank/drug/DB04619/identifier/pdb/
n11http://linked.opendata.cz/resource/drugbank/drug/DB04619/identifier/pubchem-compound/

Statements

Subject Item
n2:DB04619
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB04619 n8:DB04619
dcterms:title
ACETOPHENONE
adms:identifier
n10:AC0 n11:7410 n12:27632 n13:DB04619 n14:46507681
n3:synthesisReference
Wolfgang Kramer, "Preparation of .omega.-azolyl-acetophenone oxide ethers employing .omega.-halogeno-acetophenone oxide ethers." U.S. Patent US4293715, issued December, 1967.
n3:IUPAC-Name
n4:271B43DE-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B43E4-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B43E3-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B43E0-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B43E1-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B43E2-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B43DC-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B43DA-363D-11E5-9242-09173F13E4C5 n4:271B43DD-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B43DB-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B43EA-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B43EB-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B43E5-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B43E6-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B43E8-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B43E7-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B43E9-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B43F0-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B43F2-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B43F3-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B43EF-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B43EE-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B43F1-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B43DF-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B43EC-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B43ED-363D-11E5-9242-09173F13E4C5